Background: Home oxygen therapy is a mainstay of treatment for patients with various cardiopulmonary diseases. In spite of warnings against smoking while using home oxygen, many patients sustain burn injuries. Objectives: We aimed to quantify the morbidity and mortality of such patients admitted to our regional burn unit over a 6-year period. Methods: A retrospective chart review of all patients admitted to a regional burn center from 2008 through 2013 was completed. Admitted patients sustaining burns secondary to smoking while using home oxygen therapy were selected as the study population to determine morbidity. Results: Fifty-five subjects were admitted to the burn unit for smoking-related home oxygen injuries. The age range was 40-84 years. Almost all subjects were on home oxygen for chronic obstructive pulmonary disease (96%). Seventy-two percent of burns involved <5% of the total body surface area, 51% of patients were intubated, and of those 33% had evidence of inhalation injury. The hospital mortality rate was 14.5%. The mean length of hospital stay was 8.6 days, and 54.5% were discharged to a nursing home or another advanced facility. Finally, concomitant substance abuse was found in 27%, and a previous history of injury from smoking while on home oxygen was discovered in 14.5%. Conclusions: This single-center analysis is one of the largest describing burn injuries stemming from smoking while using home oxygen therapy. We identified the morbidity and mortality associated with these injuries. Ongoing education and careful consideration of prescribing home oxygen therapy for known smokers is highly encouraged.

Keywords:
Smoking, Home oxygen therapy, Chronic obstructive pulmonary disease, Combustion injury, Burns, Substance abuse
1.
Ward MM, Javitz HS, Smith WM, Bakst A: Direct medical cost of chronic obstructive pulmonary disease in the USA. Respir Med 2000;94:1123-1129.
2.
Dunne PJ: The demographics and economics of long-term oxygen therapy. Respir Care 2000;45:223-228.
3.
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;1:681-686.
4.
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93:391-398.
5.
Vercruysse GA, Ingram WA: A rationale for significant cost savings in patients suffering home oxygen burns: despite many comorbid conditions, only modest care is necessary. J Burn Care Res 2012;33:e268-e274.
6.
Indiana Network for Patient Care. http://www.ihie.org/indiana-network-for-patient-care.
7.
Research Electronic Data Capture (REDCap) database. http://redcap.uits.iu.edu.
9.
Murabit A, Tredget EE: Review of burn injuries secondary to home oxygen. J Burn Care Res 2012;33:212-217.
10.
Amani H, Lozano DD, Blome-Eberwein S: Brother, have you got a light? Assessing the need for intubation in patients sustaining burn injury secondary to home oxygen therapy. J Burn Care Res 2012;33:e280-e285.
11.
Murabit A, Tredget EE: Review of burn injuries secondary to home oxygen. J Burn Care Res 2012;33:212-217.
12.
Galligan CJ, Markkanen PK, Fantasia LM, Gore RJ, Sama SR, Quinn MM: A growing fire hazard concern in communities: home oxygen therapy and continued smoking habits. New Solut 2015;24:535-554.
13.
Al Kassis S, Savetamal A, Assi R, Crombie RE, Ali R, Moores C, et al: Characteristics of patients with injury secondary to smoking on home oxygen therapy transferred intubated to a burn center. J Am Coll Surg 2014;218:1182-1186.
14.
Litt EJ, Ziesche R, Happak W, Lumenta DB: Burning HOT: revisiting guidelines associated with home oxygen therapy. Int J Burns Trauma 2012;2:167-170.
15.
Russi EW, Karrer W, Brutsche M, Eich C, Frey M, Geiser T, et al: Diagnosis and management of chronic obstructive pulmonary disease: the Swiss guidelines. Official guidelines of the Swiss Respiratory Society. Respiration 2013;85:160-174.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.